# Nicardipine vs. Labetalol

> **NCT07277283** · PHASE4 · COMPLETED · sponsor: **Haseki Training and Research Hospital** · enrollment: 34 (actual)

## Conditions studied

- Acute Ischemic Stroke
- Hypertensive Crisis

## Interventions

- **DRUG:** nicardipine intravenous
- **DRUG:** labetalol intravenous

## Key facts

- **NCT ID:** NCT07277283
- **Lead sponsor:** Haseki Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07277283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07277283, "Nicardipine vs. Labetalol". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07277283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*